High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA Platform

Carterra's High-throughput Epitope Analysis and the Latest in Antibody DiscoveryПодробнее

Carterra 100th LSA-Platform Shipped | Best Novel Therapeutic Solution | High-res Epitope BinningПодробнее

Carterra 2022 Symposium | High-Throughput Antibody Screening | LSA PlatformПодробнее

Carterra Live @ PEGS Europe 2021 | High-Throughput Antibody Screening | LSA Platform | BiotechnologyПодробнее

AET Europe 2023: The new Carterra LSA-XT and HT-SPR characterization of multi-specific antibodiesПодробнее

DDN | Aviva Systems Biology | Carterra 2023 webinar | High Throughput Antibody CharacterizationПодробнее

Improve Therapeutic Antibody Screening | Leverage HT-SPR to Complement AlphaLISA | LSA PlatformПодробнее

HT-SPR Technology | High-Throughput Antibody Screening | Biology Solutions | LSA PlatformПодробнее

Therapeutic Antibodies in Post Genomics Era | High-Throughput Antibody Screening | LSA PlatformПодробнее

Develop High Quality Therapeutic Antibodies Straight From Selections in Record TimeПодробнее

High Quality Therapeutic Antibodies | High-Throughput Antibody Screening | HT-SPR | LSA PlatformПодробнее

Accelerating Drug Discovery at a Pandemic Pace | High-res Epitope Binning | HT-SPR | LSA PlatformПодробнее

HT-SPR Technology Across Discovery Platforms | Therapeutic Antibody Screening | Novel TherapeuticsПодробнее

Screen biotherapeutic targets using Carterra's software suite | High-Throughput Antibody ScreeningПодробнее

Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies | High-Throughput Antibody ScreeningПодробнее

Surface Plasmon Resonance (SPR) Essentials & Principles of High Throughput Kinetic AnalysisПодробнее

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike ProteinПодробнее

Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants | Biotechnology | LSA PlatformПодробнее